Biotech
SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – NGHC, MXIM, OTEL, PFNX
NEW YORK, NY / ACCESSWIRE / August 29, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: National General Holdings Corp. (NASDAQ:NGHC) concerning potential violations of the federal securities laws more...
Biotech
CohBar Announces Closing of Public Offering of Common Stock and Warrants
MENLO PARK, Calif., Aug. 28, 2020 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR) (the “Company”), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced the more...
Biotech
EQUITY ALERT: ROSEN, A LEADING AND TOP RANKED LAW FIRM, Announces Investigation of Securities Claims Against Fennec Pharmaceuticals Inc.; Encourages Investors with Large Losses to Contact the Firm – FENC
NEW YORK, NY / ACCESSWIRE / August 28, 2020 / Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Fennec Pharmaceuticals Inc. (NASDAQ:FENC) more...
Biotech
Intercept (ICPT) Posts New Positive Results on NASH Drug
Intercept Pharmaceuticals, Inc. ICPT announced new positive data on obeticholic acid (OCA) for the indication of nonalcoholic steatohepatitis (NASH) from the late-stage study REGENERATE at the virtual International Liver Congress 2020, the 55th Annual Meeting more...
Biotech
Fortress Biotech Announces Positive Topline Clinical Efficacy Results for CUTX-101, Copper Histidinate, for the Treatment of Menkes Disease
Statistically Significant Improvement in the Primary Endpoint of Overall Survival in Menkes Disease Patients who Received Early Treatment with CUTX-101, Compared to an Untreated Historical Control, with a Nearly 80% Reduction in the Risk of more...
Biotech
Entasis Therapeutics Announces $25 Million Private Placement
Proceeds to support the ongoing ATTACK Phase 3 registration clinical trial WALTHAM, Mass., Aug. 28, 2020 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX) (“Entasis”), a clinical-stage biopharmaceutical company focused on the discovery and more...
Biotech
AnPac Bio to Report its First Six Months 2020 Financial Results on Thursday, September 10, 2020
Earnings Call Scheduled for 8:00 am ET on September 10, 2020 SAN JOSE, Calif., Aug. 28, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology more...
Biotech
MERGER ALERT – CGIX, PRNB, and MNTA: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies
NEW YORK, NY / ACCESSWIRE / August 27, 2020 / The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of more...
Biotech
Yes, You Can Time the Market. Find out How – August 27, 2020
Being that unique investor who has the power to consistently time the market and always make a profit is the dream for most people who trade their own accounts. Indeed, even among those investors who more...
Biotech
Citius Pharmaceuticals to Present at the LD 500 Virtual Conference
CRANFORD, N.J., Aug. 27, 2020 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today that it will be presenting at more...